期刊文献+

奎硫平与氯氮平对精神分裂症患者生活质量影响的对照研究 被引量:4

Comparative study of effects of quetiapine and clozapine on quality of lift of schizophrenics
下载PDF
导出
摘要 目的 探讨奎硫平与氯氮平对精神分裂症患者生活质量的影响。方法 随机将入组的 6 3例患者分为奎硫平治疗组31例 ,剂量为 2 0 0~ 5 0 0mg·d-1,平均 310 .15± 98.33mg·d-1;氯氮平治疗组 32例 ,剂量为 2 0 0~ 6 0 0mg·d-1,平均 380 .4 5±90 .16mg·d-1。应用阳性与阴性症状量表 (PANSS)、生活质量综合评定问卷 (GQOLI 74 )分别于治疗前后评估患者的生活质量与疗效。结果 治疗 3mo后 ,两组患者的PANSS总分、阳性因子、阴性因子评分与治疗前比较均有极显著性差异 (P <0 .0 1) ,两组间PANS总分、阳性因子、阴性因子评分均无显著性差异 (P >0 .0 5 )。奎硫平组躯体健康维度、社会功能维度得分高于氯氮平组 ,差异均有显著性 (P <0 .0 5 )。结论 奎硫平、氯氮平对精神分裂症的疗效相当 。 Objective To explore the effects of quetiapine and clozapine on life's quality of schizophrenics. Methods 63 patients were randomly divided into quetiapine group(n=31,mean dose 310.15±98.33mg/d) and clozapine group(n=32, mean dose 380.45±90.16mg/d).The quality of life and curative effect's were assessed with the GQOLI-74 and PANSS before and after treatment respectively. Results After 3 month treatment, scores of PANSS of both the 2 groups were significantly decreased compared with pre-treatment(P<0.01) and had no difference between the 2 groups(P>05). Scores of somatic health and social function were higher in the quetiapine group than in the clozapine group, which showed significant difference(P<0.05). Conclusion The curative effects of the two drugs are corresponding, but quttiapine is better in the improvement of life's quality than clozapine.
出处 《临床心身疾病杂志》 CAS 2004年第3期167-168,共2页 Journal of Clinical Psychosomatic Diseases
关键词 奎硫平 氯氮平 精神分裂症 生活质量 Quetiapine clozapine schizophrenia quality of life
  • 相关文献

参考文献7

  • 1Goochc,loff. Factors affecting the success of community placement: The TAPS project[J]. Psychological medicine,1996,26:511
  • 2Sanguineti VR, Samuel SE, Schwartz SL, et al. Retrospective study of 2, 200 involuntary psychiatric admissions and readmissions[J]. American Joumal of Psychiatry, 1996,153:392
  • 3Awad AG. Subjective response to neurolepties and quality of life implications for treatment outcome[J]. Acta Psychiatrica Scandinarica, 1994,89(380): 27
  • 4汪向东 王希林 马弘.心理卫生评定量表手册,(增订版)[M].北京:中国心理卫生杂志社,1999.88-100.
  • 5Spilker B (ed). Quality of Life Assessments in Clinical Trials[M]. New York: Raven Press Ltd, 1990: 237~ 255
  • 6Simpson CJ, Hyde CE. Faragher EB. The chromically mentally ill in community facilities[J]. British Journal of Psychiatry, 1989,154(4): 77
  • 7曹秋云,江开达.奎硫平国外资料介绍[J].临床精神医学杂志,2002,12(4):229-230. 被引量:164

二级参考文献13

  • 1[1]Goldstein JM. Atypical antipsychotic drugs :beyond acute psychosis, new directions. Emerging Drugs, 1999,4:127
  • 2[2]Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry,1997,54:549
  • 3[3]Borison RL, Arvanitis LA, Miller BG. ICI 204.636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. US Seroquel Study Group. J Clin Psychopharmacol, 1996,16:158
  • 4[4]Arvanitis LA,Miller BG and the Seroquel Trial 13 Group.Multiple fixed doses of "Seroquel"(quetiapine) in patients with acute exacerbation of schizophrenia:a comparison with haloperiadaol and placebo.Biol Psychiatry,1997,42:233
  • 5[5]Beasley CM,Sanger T,Satterlee W,et al.Olanzapine versus placebo:results of double-blind,fixed dose olanzapine trail.Psychopharmacology,1996,124:159
  • 6[6]Tran PV,Hamilton SH,Kuntz AJ,et al.Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.J Clin Psychopharmacol,1997,17:407
  • 7[7]Kasper S,Muller-Spahn F.Review of quetiapine and its clinical applications in schizophrenia.Exp Opin Pharmacother,2000,1:783
  • 8[8]Purdon S,Malla A,Labelle A,et al.Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.J Psychiatr Neurosci,2001,26:137
  • 9[9]Hellwell J,Mckeller M,Raniwalla J."Seroquel":efficacy in aggression,hostility and low mood of schizophrenia [abstract].Presented at the CINP Congress,1998,Glasgow UK
  • 10[10]Tariot PH,Salzman MD,Yeung PP,et al.Long-term use of quetiapine in elderly patients with psychotic disorders.Clin Ther,2000,22:1068

共引文献167

同被引文献18

  • 1潘苗,王涵,张三强,赵峥,姚风菊.国产奎硫平与利培酮治疗首发精神分裂症对照研究[J].临床心身疾病杂志,2004,10(4):244-246. 被引量:7
  • 2卢振胜,李梅,姜振玲,陈忠,王松梅,毛丽,宋思佳.奎硫平对精神分裂症患者生活质量研究[J].临床精神医学杂志,2003,13(4):202-203. 被引量:18
  • 3南京市卫生局.医药科技进展[M].北京:中国医药科技出版社,2003,427,429,431.
  • 4何燕玲.阳性与阴性症状量表[M].中国心理卫生杂志社,1999(增订版):567.
  • 5Vorugantion L.Novel antipsychotics improve quality of life in routient clinical practice[J].Schizophrenia Res,2000,439(2):135-139.
  • 6Vongantio L.Novel antipsychotics improve quality of in routine clinical practice[J].Schizophrenia Research,2000,43:135.
  • 7Keefe RSE.Denovel antipsychofics improve cognition?A report of a meta analysis[J].Psychiatric Ann,1999,29:623.
  • 8汪向东 王希林 马弘 等.心理卫生评定量表手册[M]:增订版[M].北京:中国心理卫生杂志社,1999.306-310.
  • 9汪向东 王希林 马弘.心理卫生评定量表手册[M](增订版)[M].长沙:中国心理卫生杂志社,1999.35-90.
  • 10王泉英,刘玉元,张陆云.利培酮与氯氮平对精神分裂症患者生活质量影响的比较[J].四川精神卫生,2007,20(4):196-198. 被引量:6

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部